Roger E. Susi - Jun 21, 2021 Form 4 Insider Report for IRADIMED CORP (IRMD)

Signature
/s/ Roger E. Susi
Stock symbol
IRMD
Transactions as of
Jun 21, 2021
Transactions value $
-$278,695
Form type
4
Date filed
6/23/2021, 07:13 PM
Next filing
Jun 29, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRMD Common Stock Sale -$31.1K -1.09K -5.2% $28.48 19.9K Jun 21, 2021 Direct F1, F2
transaction IRMD Common Stock Sale -$139K -5K -25.12% $27.77 14.9K Jun 22, 2021 Direct F1, F3
transaction IRMD Common Stock Sale -$109K -3.91K -26.21% $27.82 11K Jun 23, 2021 Direct F1, F4
holding IRMD Common Stock 985K Jun 21, 2021 By Roger E. Susi Revocable Trust F5
holding IRMD Common Stock 2.36M Jun 21, 2021 By Matthew Susi 2008 Dynasty Trust F5
holding IRMD Common Stock 2.36M Jun 21, 2021 By Phillip Susi 2008 Dynasty Trust F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2021.
F2 This transaction was executed in multiple trades at prices ranging from $28.40 to $28.70. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $27.50 to $28.38. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $27.51 to $28.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose.